DP
David P Perry
Executive Chairman

David P Perry insider trades: Better Therapeutics (BTTX) stock buys and sales

Executive Chairman, Better Therapeutics Last trade Jul 27, 2023 20 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2013
3
Companies
last trade 2023

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where David reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jul 27, 2023BTTX↑ Buy$900K
Apr 10, 2023BTTX↑ Buy$3.0M
Apr 10, 2023BTTX↑ Buy$1.1M
Sep 16, 2022BTTX↑ Buy$103K
Oct 28, 2021BTTX↑ Buy$2.0M
May 26, 2021BTTX↑ Buy$512K
Mar 5, 2014ANAC↓ Sell$1.3M
Feb 5, 2014ANAC↓ Sell$255K
Jan 9, 2014ANAC↓ Sell$1.1M
Dec 9, 2013ANAC↓ Sell$655K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About David P Perry's insider trades

David P Perry is Executive Chairman at Better Therapeutics (BTTX). Since Dec 9, 2013, David has reported 6 open-market purchases worth $7.6M and 4 sales worth $3.3M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (13 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BTTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.